Spectral AI (MDAI) announced the completion of its pediatric enrollment at U.S. emergency departments for its U.S. Burn Pivotal Study. One of the largest domestic burn studies ever conducted, the U.S. Burn Pivotal Study is designed to validate the AI-driven algorithm used by the Company’s DeepView System for burn indication. Using data from these burn center patients, the company will pursue a De Novo classification from the U.S. FDA for use of the DeepView System and expects to submit the request in the first half of 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDAI:
- Spectral AI sees FY24 revenue exceeding $28M, consensus $28.65M
- Spectral AI provides instructions on exercising publicly-traded warrants
- Spectral AI Regains Nasdaq Compliance, Eyes FDA Submission
- Spectral AI announces confirmation of compliance of Nasdaq listing requirements
- Spectral AI comments on compliance with Nasdaq listing rule
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue